SpaceX Stock Is Now Trading. Should You Buy SPCX Today?

SpaceX is described as generating $18.7 billion in 2025 revenue, with Starlink contributing nearly $12 billion at about 40% operating margins, while the company still lost just under $5 billion overall. The article argues the newly public stock is priced for perfection at $1.77 trillion, or roughly 94x 2025 sales, and urges investors to wait as IPOs often trade lower after debut. The piece is more of a valuation cautionary note than a business update.

Analysis

The immediate market read-through is less about SpaceX itself and more about what a frothy private-market print does to the broader AI/space complex. A $1.77T debut at ~94x revenue effectively resets the bar for late-stage venture pricing and likely compresses expected returns across adjacent private rounds, especially for capital-intensive “frontier tech” names with weaker unit economics. That is mildly negative for public comps with similar narrative premium, while being only modestly supportive for hardware enablers until investors separate real cash generation from story stock scarcity.

The biggest second-order issue is liquidity. Once lockups, employee sales, and secondary listings start, supply could flood into a market that is already paying up for optionality, which typically matters more over the next 1-3 quarters than the headline IPO itself. If early holders use the public tape to de-risk, the stock can underperform even without a fundamental miss, simply because incremental buyers need new information to justify another multiple expansion.

For the named public beneficiaries, the signal is mixed: NVDA gets a small sentiment tailwind from “AI can be priced at any scale” narratives, but the setup is far less durable than for firms whose cash flows are already visible and recurring. TSLA and META are more vulnerable to relative multiple pressure because both trade partly on ecosystem dominance and future platform monetization; a failed post-IPO pop in SpaceX would undercut that scarcity premium. NFLX is mostly insulated fundamentally, but it can still benefit on a factor basis if investors rotate away from long-duration growth stories after the IPO excitement fades.

The contrarian view is that this is closer to a sentiment peak than a valuation floor. The market may be underestimating how much performance this deal needs just to justify private-market marks, let alone public-market expectations; that gap often widens before it narrows. In that regime, the best risk/reward is not chasing the new issue but fading the exuberance in the most sentiment-sensitive megacaps and waiting for a post-lockup dislocation.

Key Decisions for Investors

• Short-term: avoid initiating fresh longs in the SpaceX complex for 4-8 weeks; wait for secondary supply and lockup talk to create a better entry point. Risk/reward is poor here because upside requires multiple expansion, while downside can come from supply alone.
• Long NVDA / short TSLA as a 1-3 month relative-value trade. NVDA has cleaner cash conversion and less dependence on IPO sentiment; TSLA is more exposed to multiple compression if frontier-tech enthusiasm cools.
• Short META on any post-IPO sympathy rally over the next 2-6 weeks. The thesis is not business deterioration, but that the market may re-rate long-duration platform names lower if the new issue trades weakly after the debut.
• Use NFLX as the defensive long in a growth-factor rotation basket over the next quarter. If the IPO fades, capital should migrate toward lower-variance compounding stories, and NFLX’s earnings visibility makes it a better shelter than hype-beta names.
• If you want exposure to the theme, express it via a small call spread on NVDA rather than owning the new issue outright. Cap downside, keep upside tied to the AI narrative, and avoid the binary risk of a post-IPO valuation reset.